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Abstract—Recently it has been demonstrated that catecholamines are produced and used by macrophages and mediate
immune response. The aim of this study is to verify whether endothelial cells (ECs), which are of myeloid origin,
can produce catecholamines. We demonstrated that genes coding for tyrosine hydroxylase, Dopa decarboxylase,
dopamine  hydroxylase (DH), and phenylethanolamine-N-methyl transferase, enzymes involved in the synthesis
of catecholamines, are all expressed in basal conditions in bovine aorta ECs, and their expression is enhanced in
response to hypoxia. Moreover, hypoxia enhances catecholamine release. To evaluate the signal transduction
pathway that regulates catecholamine synthesis in ECs, we overexpressed in bovine aorta ECs either protein kinase
A (PKA) or the transcription factor cAMP response element binding, because PKA/cAMP response element
binding activation induces tyrosine hydroxylase transcription and activity in response to stress. Both cAMP
response element binding and PKA overexpression enhance DH and phenylethanolamine-N-methyl transferase
gene expression and catecholamine release, whereas H89, inhibitor of PKA, exerts the opposite effect, evidencing
the role of PKA/cAMP response element binding transduction pathway in the regulation of catecholamine release
in bovine aorta ECs. We then evaluated by immunohistochemistry the expression of tyrosine hydroxylase, Dopa
decarboxylase, DH, and phenylethanolamine-N-methyl transferase in femoral arteries from hindlimbs of C57Bl/6
mice 3 days after removal of the common femoral artery to induce chronic ischemia. Ischemia evokes tyrosine
hydroxylase, Dopa decarboxylase, DH, and phenylethanolamine-N-methyl transferase expression in the endo-
thelium. Finally, the pharmacological inhibition of catecholamine release by fusaric acid, an inhibitor of DH,
reduces the ability of ECs to form network-like structures on Matrigel matrix. In conclusion, our study
demonstrates for the first time that ECs are able to synthesize and release catecholamines in response to ischemia.
(Hypertension. 2012;60:129-136.) ● Online Data Supplement
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Endothelial cells (ECs) cover the interior surface of bloodvessels throughout the entire circulatory system, and they
are involved in many aspects of vascular biology.1–4 Indeed,
angiogenesis is a phenomenon intimately associated with EC
migration and proliferation during embryonic development.5
Similarly, ECs play major roles in immune and inflammatory
reactions by regulating lymphocyte and leukocyte migration
into tissues by means of direct interaction with ECs.6 More-
over, ECs have an important role in the regulation of the
vascular tone by releasing vasoactive agents controlling
smooth muscle cell proliferation and contractility.
Indeed, ECs are known to release both vasodilators
(NO) and vasoconstrictors (thromboxane, platelet-derived
growth factor, and endothelin 1) in response to local and
circulating stimuli.7–14 To this purpose, the endothelium is
regulated in a fine way by a series of receptors that are
expressed on its surface, including adrenergic receptors
(ARs), such as 1 and 2AR.15,16 Circulating cat-
echolamines are thought to be the natural agonist of these
receptors, giving the fact that ECs are not reached by
sympathetic innervation.1
The endothelium derives from the embrional mesenchimal
sheet, so it does the population of myeloid lineage-restricted
bone marrow progenitors.17 The common features between
the 2 lineages are suggested by the observation that endothe-
lial progenitors are released in the bloodstream from bone
Received December 13, 2011; first decision January 3, 2012; revision accepted May 1, 2012.
From the Dipartimento di Medicina Clinica (D.S., G.S., C.D.G., A.A., B.T.), Scienze Cardiovascolari ed Immunologiche, Università Federico II,
Naples, Italy; Università degli Studi di Salerno (G.I.), Salerno, Italy, Istituto Di Ricovero e Cura a Carattere Scientifico Multimedica (G.I.), Milan, Italy.
The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/doi:10.1161/HYPERTENSIONAHA.
111.189605/-/DC1.
Correspondence to Guido Iaccarino, Department of Medicine and Surgery, Università di Salerno, Via Salvador Allende, 84081 Baronissi (SA), Italy.
E-mail giaccarino@unisa.it
© 2012 American Heart Association, Inc.
Hypertension is available at http://hyper.ahajournals.org DOI: 10.1161/HYPERTENSIONAHA.111.189605
129  by guest on February 1, 2016http://hyper.ahajournals.org/Downloaded from 
marrow myelocytic progenitors.18 This finding is consistent
with results from several laboratories that have reported
circulating cells with myeloid features contributing to human
angiogenesis.19–22
Circulating catecholamines, dopamine, norepinephrine
(NE), and epinephrine (EPI), regulate vascular tone via AR
activation, leading to vasoconstriction in most systemic
arteries and veins. They are synthesized from the amino acid
precursor l-tyrosine. Tyrosine hydroxylase (TH) is the first
rate-limiting enzyme in catecholamine synthesis that cata-
lyzes the conversion of tyrosine to l-dihydroxyphenylalanine.
This latter is converted to dopamine by Dopa decarboxylase
(DDC). On turn, dopamine is converted to NE by dopamine
 hydroxylase (DH), and NE is converted to EPI by
phenylethanolamine-N-methyl transferase (PNMT).23–26
Once released, catecholamines are quickly inactivated by 2
enzymes that are responsible for their catabolism, catechol-
oxymethyltransferase and monoamine oxidase.27,28 Mono-
amine oxidase catalyzes the oxidative deamination of amines,
and catechol-oxymethyltransferase methylates the hydroxyl
group meta to the side chain of catecholamines.29 Until a few
years ago, catecholamines were considered mainly as con-
ventional neurotransmitters and neuroendocrine mediators,
synthesized in the adrenal medulla. However, it has been
demonstrated recently that they are also produced and used
by cells of the immune system.30–36 Indeed, catecholamines
are actively produced by macrophages and have the capacity
to act in an autocrine way on ARs to regulate macrophage
production of interleukin 1, which has a key role in the
inflammatory response.37
Giving the common myeloid origin of ECs and macro-
phages and the ability of cells of the immune system to
produce catecholamines, the aim of this study was to verify
whether ECs were also able to autonomously synthesize and
release catecholamines for signaling purposes.
Materials and Methods
All of the experiments were performed as described previously.38
Extended details of Methods are described in the online-only Data
Supplement.
Results
ECs Produce Catecholamines
To assess the ability of ECs to synthesize catecholamines, we
first evaluated the expression of genes coding for the en-
zymes involved in the synthesis of catecholamines by real-
time RT-PCR both in basal conditions and in response to
hypoxia. We performed a time course experiment evaluating
enzyme gene expression at 1, 3, 6, 16, and 24 hours of
hypoxia (Figure 1A). Hypoxia-induced TH, DDC, DH, and
PNMT gene expressions respect to basal conditions in a
time-dependent manner. At 16 hours of hypoxia, we found
the maximum expression of these enzymes, and then cells
start to die. Based on such data, we chose to incubate cells in
hypoxic conditions for 16 hours, because it is an intermediate
time between enzyme maximum expression and cell death.
We confirmed this result by Western blot analysis. Figure 1B
shows that hypoxia increased protein levels of TH, DDC,
DH, and PNMT in whole cell lysates. Total lysate from
mouse adrenal glands and spleens were used, respectively, as
positive and negative controls. We also verified enzyme
expression in bovine aorta ECs by immunohistochemistry.
TH, DDC, DH, and PNMT were all expressed in basal
condition, and their expression was enhanced by hypoxic
stimulus (Figure S1, available in the online-only Data Sup-
plement). Immunohistochemistry shows that DDC, DH, and
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Figure 1. Endothelial cells synthesize catecholamines in
response to hypoxia. A, RNA from bovine aorta endothelial cells
(BAECs) was converted to cDNA and analyzed by real-time PCR
to evaluate the expression of tyrosine hydroxylase (TH), Dopa
decarboxylase (DDC), dopamine  hydroxylase (DH), and
phenylethanolamine-N-methyl transferase (PNMT) in response to
hypoxia (1, s; 3, ; 6, vertical lines; 16, o; and 24 hours, dot-
ted). All of the enzymes are expressed in basal conditions and
hypoxia enhanced their expression in a time-dependent manner;
*P0.05 vs normoxia. Results are the mean of 5 independent
experiments. B, TH, DDC, DH, and PNMT levels were evalu-
ated in whole cell lysates by Western blot. Hypoxia increases
TH, DDC, DH, and PNMT levels. Lysates from adrenal gland
and spleen were used, respectively, as positive and negative
controls. Actin was used as loading control. Images are repre-
sentative of 3 independent experiments. C, Catecholamines
release was evaluated by ELISA assay in the culture medium of
BAECs in basal conditions and after 16 hours of hypoxia. Hyp-
oxia induces both norepinephrine (NE) and epinephrine (EPI)
release. *P0.05 vs normoxia. Results are the mean of 5 inde-
pendent experiments. e, normoxia; , hypoxia.
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PNMT presented a cytosolic and perinuclear localization,
whereas TH was mainly localized in the nucleus. Finally, to
confirm the ability of bovine aorta ECs (BAECs) to produce
catecholamines, we analyzed NE and EPI release in the
culture medium by ELISA assay (Figure 1C). Hypoxia
enhanced both NE and EPI release with respect to normoxia.
Hypoxia Regulates Catecholamine Synthesis in EC
by Activation of Protein Kinase A/cAMP Response
Element Binding Signaling
To assess the signal transduction pathway that regulates
catecholamine synthesis in ECs, we evaluated protein kinase
A (PKA) signaling, because it is known that PKA/cAMP
response element binding (CREB) activation induces TH
transcription and activity in response to stress.39,40 We first
analyzed by Western blot the effect of hypoxia on the
activation of CREB and PKA. Figure 2A shows that hypoxia
induces the expression of the phosphorylated and activated
forms of both CREB and PKA, confirming that, also in
BAECs, hypoxia regulates PKA/CREB signaling. Based on
such data, we evaluated whether hypoxia-induced PKA/
CREB activation regulates catecholamine synthesis in
BAECs. In these experiments, we focused on DH and
PNMT expression, being the key enzymes for NE and EPI
synthesis. To assess whether this signaling was involved in
the regulation of catecholamine synthesis, we pharmacolog-
ically inhibited PKA/CREB signaling using a selective inhib-
itor of PKA, H89. This latter inhibited hypoxia induced DH
and PNMT gene expression (DH, 73.70.03% and
PNMT, 75.20.04% versus hypoxia; Figure 2B) and pre-
vented hypoxia-evoked increase of DH and PNMT protein
levels (Figure 2C). To further confirm these data, we used a
peptidic inhibitor of PKA (PKA-I), which is more specific
and selective respect to H89. PKA-I reduced both DH and
PNMT protein levels in response to hypoxia (Figure 2D).
These data demonstrate that, in BAECs, hypoxia induces
PKA/CREB signaling, and the activation of this pathway
regulates catecholamine synthesis. To confirm these results,
we overexpressed in BAECs both PKA and CREB by means
of transient transfection. Both CREB and PKA overexpres-
sion enhanced DH (CREB, 2.10.09; PKA, 62.01-
fold of basal) and PNMT (CREB, 9.80.3; PKA,
5.61.7-fold of basal) gene expression in basal conditions
(Figure 2E). PKA overexpression further enhanced the re-
sponse to hypoxia (DH 160.6 and PNMT 9.60.2
versus hypoxia; Figure 2E). Accordingly, Western blot anal-
ysis showed that CREB and PKA overexpression increased
DH and PNMT protein levels, and PKA overexpression
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Figure 2. Endothelial cell (EC) regulates catecholamine release by hypoxia-induced protein kinase A (PKA)/cAMP response element
binding (CREB) signaling activation. A, We evaluated hypoxia-induced CREB and PKA activation by Western blot using an antibody
against the phosphorylated form of CREB and PKA. Hypoxia induces both CREB and PKA activation. Images are representative of 3
independent experiments. B and C, To evaluate the effect of PKA/CREB signaling on catecholamines release in bovine aorta ECs
(BAECs), we analyzed by real-time PCR and Western blot the expression of dopamine  hydroxylase (DH) and phenylethanolamine-N-
methyl transferase (PNMT) in response to a selective inhibitor of PKA, H89. H89 inhibits both DH and PNMT gene expression (B) and
protein levels (C) in response to hypoxia. Actin was used as loading control for western blot analysis; *P0.05 vs normoxia, #P0.05
vs hypoxia. Results are the mean of 5 independent experiments. B, e, normoxia; , hypoxia; horizontal stripe, hypoxiaH89. D, To
confirm the involvement of PKA in this phenomenon, we inhibited PKA activity by means of a peptidic inhibitor that is more selective
and specific respect to H89, peptidic inhibitor of PKA (PKA-I). PKA-I inhibits both DH and PNMT protein levels in response to hypoxia.
Actin was used as loading control. E and F, To confirm these data, we overexpressed in cells CREB and PKA by transient transfection
and analyzed DH and PNMT levels. Both CREB and PKA overexpression increase DH and PNMT gene expression (E) and protein
levels (F) both in basal condition and in response to hypoxia. Actin was used as loading control for Western blot analysis; *P0.05 vs
normoxia, #P0.05 vs hypoxia. Images are representative of 3 independent experiments. E, e, basal; s, CREB; , PKA; vertical lines,
hypoxia; o, hypoxiaCREB; dots, hypoxiaPKA.
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further increased the response to hypoxia (Figure 2F). More-
over, PKA/CREB signaling also regulated catecholamine
release in the culture medium (Figure S2). Indeed, H89
inhibited hypoxia-induced NE (Figure S2A) and EPI (Figure
S2B) release. CREB overexpression caused NE (Figure S2C)
and EPI (Figure S2D) release. In these conditions, hypoxia
was no longer able to induce further accumulation (Figure
S2C and S2D). Also, PKA overexpression increased cate-
cholamine release (Figure S2C and S2D), and in these cells
hypoxia was still able to induce a modest increase of
catecholamine release. These data indicate that hypoxia-
induced activation of the PKA/CREB signaling transduction
pathway regulates catecholamine synthesis and release in
BAECs.
Endothelium Produces Catecholamines In Vivo
To confirm in vitro data, we evaluated in vivo by immuno-
histochemistry the expression of TH, DDC, DH, and PNMT
in superficial femoral arteries from hindlimbs of C57Bl/6
mice 3 days after surgery. Ischemia induced DDC, DH, and
PNMT expression in the endothelium of femoral arteries
(Figure 3A) and in capillaries, highlighted in the femoral
muscle by lectin staining (Figure 3B). On the contrary, TH
was maximally expressed in the cytoplasm of muscle cells,
although a higher magnification also revealed an endothelial
localization. Negative control with secondary antibody only was
shown in Figure S3.
Endothelium-Dependent Catecholamine Release
Has a Key Role in Angiogenesis In Vitro
To evaluate the physiopathological role of endothelium-
dependent catecholamine release in vitro, we evaluated the
ability of BAECs to form network-like structures on Matrigel
matrix in the presence or absence of a selective inhibitor of
DH, fusaric acid (FA). Figure S4 shows that hypoxia
induced vascular network formation and FA inhibited the
response to hypoxia (Figure S4A). To confirm that the effect
of FA on angiogenesis is ascribed to its ability to inhibit
catecholamine release, we evaluated NE and EPI release in
the culture medium by ELISA assay (Figure S4B and S4C).
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Figure 3. Endothelial cell (EC) produce catecholamines in vivo. Immunohistochemical analysis of tyrosine hydroxylase (TH), Dopa
decarboxylase (DDC), dopamine  hydroxylase (DH), and phenylethanolamine-N-methyl transferase (PNMT) expression was performed
in superficial femoral arteries from hindlimbs of C57/black mice 3 days after removal of the common femoral artery. Ischemia induces
TH, DDC, DH, and PNMT expression in the endothelium of femoral arteries (A) and in capillaries (B), evidenced in the femoral muscle
by lectin staining. The expression of TH in endothelium is just evident at a higher magnification. TH is also expressed in the muscle tis-
sue, and its expression is enhanced in response to ischemia (B). Scale bar is 20 m. Images are representative of 3 independent
experiments.
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FA inhibited hypoxia-dependent catecholamine release (NE,
321.7%; EPI, 372.1% versus hypoxia). These data
suggest that ECs autonomously produce catecholamines
that have a key role in the regulation of EC proangiogenic
responses. To avoid the possibility that FA-dependent
inhibition of angiogenesis in vitro was attributed to a toxic
effect of the drug, we performed a proliferation assay using
different dosages of FA. FA turned out to be not toxic for
cells at doses from 10 nmol/L to 500 mol/L (data not
shown).
2AR Is Involved in Catecholamine-Induced
Angiogenesis in BAECs
We have demonstrated previously that 2AR has a key role in
angiogenesis both in vitro and in vivo.16,41 In particular, we
demonstrated in vivo that 2AR regulates angiogenesis in vivo
in response to ischemia, because angiogenesis is impaired in
2AR knockout mice and is ameliorated by reinstatement of
2AR. Here we tested this effect also on hypoxia-induced
angiogenesis in BAECs. To this aim we performed a real-time
PCR analysis to evaluate the effect of 2AR inhibition by the
selective inhibitor ICI 118.551 on vascular endothelial growth
factor gene expression. Our data show that 2AR blockade
is able to reduce vascular endothelial growth factor ex-
pression induced by hypoxia (Figure 4A), suggesting a key
role for this receptor in catecholamine-induced angiogenesis
in response to hypoxia. Furthermore, we evaluated whether
catecholamine-induced 2AR-dependent angiogenesis could,
in turn, be regulated by 2AR itself. To this aim, we
performed a real-time PCR experiment to evaluate DH and
PNMT gene expression in cells with selective blockade of
2AR by ICI 118.551. The blockade of 2AR inhibited both
DH (Figure 4B) and PNMT (Figure 4C) gene expression in
response to hypoxia. These data suggest that catecholamines
from ECs could promote their own synthesis in a paracrine
positive feedback manner by means of 2AR activation.
Discussion
We report here, for the first time, that ECs are capable of
synthesizing catecholamines because they have the complete
intracellular machinery for the generation and release of NE
and EPI. In vitro, ECs expressed all of the enzymes involved
in the synthesis of catecholamines in basal conditions, and
this expression is enhanced in response to hypoxia. We also
identified the molecular mechanism that regulates this phe-
nomenon. Indeed, we demonstrated that hypoxia-induced
catecholamine release in the culture medium is regulated by
the activation of PKA/CREB signaling, which is already
known to regulate most important endothelial functions, such
as endothelial NO synthase gene transcriptional activation.42
These results are paralleled by data from an in vivo model of
chronic ischemia, where we demonstrate that TH, DDC,
DH, and PNMT are expressed in the endothelium of the
femoral artery. TH expression in endothelium, despite the
other enzymes, is difficult to detect at low magnification and
needs a higher enlargement. This is because of the nuclear
localization of TH in BAECs, as demonstrated by immuno-
histochemical analysis (Figure S1), which is difficult to detect
in vivo in capillaries. Moreover, the nuclear staining is
masked by hematoxylin counterstain. This nuclear localiza-
tion of TH is suggested also by other reports, in human
epidermal melanocytes43 and in perikarya of rat ventral
tegmental area.44 Our in vivo results also show that TH is
localized in the cytoplasm of muscle cells, and it was never
described before. However, further experiments are needed to
clarify this aspect.
ECs play a critical role in the control of vascular function
because they participate in all aspects of vascular homeostasis
but also in physiological or pathological processes like
vascular wall remodeling, inflammation, or thrombosis. In
particular, they have a key role in angiogenesis, in coagula-
tion and fibrinolysis, and in the regulation of vascular tone, as
well as in inflammatory reactions and in tumor neoangiogen-
esis.45–50 ECs are capable of synthesizing and releasing a
variety of substances that may exert autocrine, paracrine, or
endocrine effects. Indeed, they contribute to the regulation of
blood pressure and blood flow by releasing vasodilators such
as NO and prostacyclin, as well as vasoconstrictors, including
endothelin and platelet-activating factor, in response to stim-
uli.14,51,52 Given the evidence that ischemia enhances plasma
levels of NE,53 it has been shown recently that cat-
echolamines contribute to arteriogenesis and angiogenesis in
pathological conditions such as hindlimb ischemia54 and that
they contribute to angiogenesis in the wound-healing pro-
cess.55 Based on our and previous data, we hypothesize that
the ability of ECs to synthesize and release catecholamines is
an autoregulatory physiological mechanism in response to
hypoxia to induce neovascularization. Indeed, the inhibition
of catecholamine release by FA reduced the proangiogenic
phenotype of ECs in vitro. This finding puts the ARs on ECs
in a different perspective. Indeed, the lack of terminal
innervations on ECs has sustained the concept that circulating
catecholamines are the natural stimulants to endothelial ARs.
Our data allow for the promoting of a new scenario in which
ECs produce catecholamines that act in a paracrine way to
sustain proangiogenic phenotypes in conditions such as isch-
emia (Figure 4D). Furthermore, these data are well in
agreement with previous reports showing the ability of ECs to
produce catecholamine catabolism enzymes, such as mono-
amine oxidase and catechol-oxymethyltransferase.56
We have identified previously the 2AR as the adrenergic
receptor involved in the regulation of angiogenesis in
ECs.16,41 Here we demonstrated that 2AR is activated by
catecholamines released by ECs to induce angiogenesis, and
it, in turn, regulates catecholamines release. A future direc-
tion of research will address the signaling linking hypoxia
and PKA/CREB activation given the potential role of this
pathway in the activation of the endothelium. In conclusion,
our study demonstrates for the first time the ability of ECs to
synthesize and release catecholamines in response to hypoxia
(in vitro) and ischemia (in vivo) and the involvement of this
phenomenon in the regulation of angiogenesis.
Perspectives
Our data indicate ECs as a source of catecholamine synthesis
and release. This is a further advance in the understanding of
endothelial function and physiology that could be useful to
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determine targeted therapies for many diseases, including
cancer, cardiovascular disease, and inflammatory conditions.
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Novelty and Significance
What Is New?
● ECs respond to stress-releasing catecholamines. These catecholamines
stimulate receptors on EC accelerating regenerating processes, such as
angiogenesis.
What Is Relevant?
● Endothelial dysfunction seen in hypertension might alter the ability of
ECs to release catecholamines in response to stress. This impairment
alters the ability of ECs to adapt to conditions such as ischemia or
inflammation.
Summary
We demonstrate that ECs present the enzymes to produce and
release NE and EPI, in response to ischemia. These substances, in
turn, further sustain the activation of endothelial function, such as
angiogenesis.
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Supplemental Methods 
 
Cell Culture 
Bovine aorta EC (BAEC), purchased from Lonza, were cultured in Dulbecco’s MEM (DMEM) 
supplemented with 10% foetal bovine serum (FBS) at 37°C in 95% air and 5% CO2. 
Plasmids 
p-CREB and p-PKA were purchased from Stratagene; p-PKA-I was a kind gift of Prof. Antonio 
Feliciello (Federico II University of Naples). Transient transfection of these plasmids was 
performed using Lipofectamine 2000 (Invitrogen) in 70% confluent BAEC, accordingly to 
manufacturer instructions.  
Hypoxia 
24 hours after transient transfection, culture medium was replaced with hypoxia-medium (116 mM 
NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 26.2 mM NaHCO3, 1 mM NaH2PO4, 1.8 mM CaCl2, 0.01 
mM glycine and 0.001 (% w/v) phenol red), previously saturated for 10 min at 1 atm with 95% N2 
and 5% CO2 mixture. In some plates H89 (10-6M, Sigma Aldrich), a selective inhibitor of PKA, 
was added to the culture medium for 30 minutes and then plates were incubated at 37°C in an 
anaerobic chamber (hypoxia chamber) filled with the same gas mixture for 16 hours.  
Western Blot  
BAEC were lysed in RIPA/SDS buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-
40, 0, 25% deoxycholate, 9,4 mg/50 ml sodium orthovanadate, 20% SDS]. Protein concentration 
was determined by using BCA assay kit (Pierce). Total extracts were electrophoresed by 
SDS/PAGE and transferred to nitrocellulose. Endogenous pCREB, pPKA, TH (Cell signaling), 
Actin, DDC, DβH and PNMT (Santacruz) were visualized by specific antibodies, anti-rabbit HRP-
conjugated secondary antibody (Santa Cruz) and standard chemiluminescence (Pierce). 
 
Immunocytochemistry and Immunohistochemistry 
Transfected cells were grown in chamber slides (Nunc, LabTek). Cells were then fixed with -20°C 
cold methanol and permeabilized with 0.01% Triton X-100 in PBS. Primary antibodies incubation 
with anti-TH, anti-DDC, anti-DbH and anti-PNMT (Santacruz) at a 1:50 dilution were performed at 
room temperature for two hours. Specific secondary antibodies (Santacruz) at a 1:100 dilution were 
incubated at room temperature for 1 hour. The peroxidase was revealed in presence of 0,03% 
hydrogen peroxide and of an electron donor, 2,5% diaminobenzidine, which becomes visible as a 
brown precipitate. Cells were then counterstained with hematoxylin, then dehydradated, cleared 
with histolemon and coverslipped. For immunohistochemistry, femoral muscles and arteries were 
fixed in formaline, embedded in paraffin and sectioned at 5 µm with a rotary microtome. Sections 
were dewaxed, rehydrated and immunostaining was performed by the peroxidase anti-peroxidase 
(PAP) method as described above. Images were taken by using an Eclipse E1000 Fluorescence 
Microscope (Nikon) and acquired by using Sigma Scan Pro software (Jandel). Images were 
optimized for contrast in Adobe PhotoShop, but no further manipulations were made.  
Real Time RT-PCR 
Total RNA was isolated using Trizol reagent (Invitrogen) and cDNA was synthetized by means of 
Thermo-Script RT-PCR System (Invitrogen), following the manufacturer instruction. After reverse 
transcription reaction, real-time quantitative polymerase chain reaction (PCR) was performed with 
the SYBR Green Real Time PCR master mix kit (Applied Biosystems). The reaction was visualized 
by SYBR Green Analysis (Applied Biosystem) on StepOne instrument (Applied Biosystem). 
Primers for gene expression analysis were as follows: 
TH:   FOR 5'AGCCTGGCCTTCCGCGTGTTCCAG3' 
REV 5'CTACGCCTCCCGCATCCAGCGCCC3'  
DDC:   FOR, 5'CCAGAGACATTTGAGGCCAT3' 
REV 5'TCCAGCCAGAAACGCCTCT3',  
DBH:   FOR 5'GAACATCAGCTATGCGCAGGA3'  
REV 5' AAAAGGCCTCTTGAAGAGCAG3'  
PNMT:  FOR 5'TACCTCCGCAACAACTACGC3' 
REV 5' CTGTATACGCTCCAGTCGAA3’  
18S:   FOR 5'GTAACCCGTTGAACCCCATT3'   
REV 5'CCATCCAATCGGTAGTAGCG3' 
VEGF:            FOR 5'CAGGCTGTCGTAACGATGAA3' 
                        REV 5'TTTCTTGCGCTTTCGTTTTT3' 
 
All values obtained were normalized to the values obtained with the 18S primers (endogenous 
control) and relative to the reference sample (basal control) using the formula 2-ΔΔCt. Obtained 
results are expressed as relative quantification (RQ). 
ELISA assay 
The release of catecholamines in the culture medium was analyzed by ELISA assay (Pantec), 
accordingly to the manufacturer instructions. Cell were transfected and incubated in the hypoxia 
chamber for 16 hours as described above. In some experiments Fusaric Acid (Sigma, 10µM) was 
added to the culture medium before hypoxic stimulus to inhibit catecholamines release. Culture 
medium was collected and used for the ELISA assay. 
Angiogenesis in vitro 
Angiogenesis in vitro was performed on Matrigel matrix as previously described 1. 
In Vivo Study.  
Experiments were carried out, in accordance to Federico II University guidelines and to 
the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals, on 12-
week-old C57Bl/6 mice, which had access to food and water ad libitum. The model of unilateral 
hindlimb (HL) ischemia was prepared as described previously 1. Briefly, anesthesia was performed 
with an intramuscular injection of a mixture of tiletamine (50 mg/kg) and zolazepam (50 mg/kg); 
the right common femoral artery was exposed, isolated and permanently closed after the emergence 
from the inguinal ligament with a non-reabsorbable suture (5–0 silk, Ethicon) whereas the femoral 
vein was clamped. Afterwards, the common femoral artery was removed and the wound closed in 
layers. After 3 days, femoral muscles and arteries were extracted from both legs of five 
animals/group, fixed in formalin and included in paraffin. Paraffin-embedded sections were stained 
for hematoxylin and eosin. Five micrometer-thick sections were processed for the triple-layered 
immunohistochemical PAP (peroxidase anti-peroxidase) method as described above. For negative 
controls, the primary anti-serum was omitted. Lectin staining (1:100, Sigma Aldrich) was used to 
identify capillaries. 
Statistical anlaysis 
All values are presented as mean±SEM. Two-way ANOVA was performed to compare the different 
parameters between the different groups. A P value < 0.05 was considered to be significant. 
Statistics were computed with GraphPad Prism version 5.01 (GraphPad Software). 
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Supplemental Figures 
  
 
Figure S1. Immunohistochemistry analysis of the expression of  TH, DDC, DβH and PNMT in 
BAEC.  
Paraffin embedded sections from adrenal gland and spleen and methanol fixed EC were analyzed by 
immunohistochemistry using the PAP peroxidase anti-peroxidase system. DDC, DβH and PNMT 
are localized in the cytosol of  EC and their expression is enhanced after 16 hours of hypoxia. TH 
present a nuclear localization. Scale bar is 20 µm. Adrenal gland was used as positive control and 
spleen as negative control. A negative control in EC was performed incubating cells with secondary 
antibody only to avoid false positive. Images are representative of 3 independent experiments. 
 
 
 
 
Figure S2: PKA/CREB regulates catecholamines release in the culture medium 
BAEC were transfected with p-CREB and p-PKA or treated with H89 and then incubated in the 
hypoxic chamber for 16 hours. Culture mediums were collected and used for ELISA assay. A-D) 
H89 inhibits catecholamines release induced by hypoxia (A-B). CREB and PKA overexpresion 
increase NE (C) and EPI (D) release respect to basal levels. PKA overexpression further increases 
the response to hypoxia; * p<0.05 vs normoxia, # p<0.05 vs hypoxia. Results are the mean of 5 
independent experiments. 
 
 
 
 
 
 
 
 
Figure S3: EC produce catecholamines in vivo: negative control  
To confirm the specificity of immunohistochemical data about TH, DDC, DβH and PNMT 
expression in BAEC (Fig. 3) we performed a negative control incubating tissues with secondary 
antibody only [femoral arteries (A) and in capillaries (B)]. 
 
Figure S4: EC dependent catecholamines release has a key role in angiogenesis in vitro. 
BAEC were treated with fusaric acid (FA, 10 µM) for 30 min and incubated in the hypoxic chamber 
for 16 hours. A) Cells were plated on matrigel matrix and the formation of network-like structures 
was analyzed by microscopy. FA inhibits hypoxia induced BAEC organization in tubular structures. 
Images are representative of 3 independent experiments. B-C) Cultured mediums were collected 
and used for ELISA assay. FA inhibits hypoxia-induced norepinephrine (NE, B) and epinephrine 
(EPI, C) release. * p<0.05 vs normoxia, # p<0.05 vs hypoxia. Results are the mean of 5 independent 
experiments.  
